Definition of Medical Event: ASTRO Report

According to § 35.2 (Definitions) of the U.S. Nuclear Regulatory Commission (NRC), a medical event means an event that meets the criteria in § 35.3045 (Records and Notifications of a Medical Event). § 35.3045(a) states, in part, a licensee “shall report any event, except for an event that results from patient intervention, in which the administration of byproduct material or radiation from byproduct material results in–

(1) A dose that differs from the prescribed dose or dose that would have resulted from the prescribed dosage by more than 0.05 Sv (5 rem) effective dose equivalent, 0.5 Sv (50 rem) to an organ or tissue, or 0.5 Sv (50 rem) shallow dose equivalent to the skin; and

(i) The total dose delivered differs from the prescribed dose by 20 percent or more.”

In permanent prostate brachytherapy, a medical event can be triggered if the total dose delivered differs from the prescribed dose by 20 percent or more [of the prescribed dose]. This definition has caused considerable concern by clinicians when performing permanent prostate brachytherapy procedures. An article published in Practical Radiation Oncologydescribes the deliberations and recommendations of a working group formed by the American Society for Radiation Oncology (ASTRO). The ASTRO working group was tasked with making recommendations for changing the definition of a medical event as it applies to permanent prostate brachytherapy.

The working group asserts the dose-based approach to defining a medical event under § 35.3045(a)(1)(i) is not acceptable for permanent prostate brachytherapy. Recommendations include drafting of a more appropriate definition for medical event in permanent prostate brachytherapy. In this effort, the working group suggests consideration of a source strength-based definition. The source strength-based approach uses a medical event trigger level of > than 20% of source strength (as intended in the post-implant written directive) that is implanted outside the intended target volume of the plan.2

1,2Naq S, Demanes DF, Hagan M, Rivard MJ, Thomadsen BR, Welsh JS, Williamson JF. Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology, Prac Radiat Oncol. 2011;4:218-223

Source: http://www.practicalradonc.org

Leave a Reply

Your email address will not be published. Required fields are marked *

MERPtm

COMPARE & VALIDATE EXPECTATIONS

MERP helps facilitate a safety culture where greater attention is directed at confirming that detailed processes are performed correctly by referencing various standards, recommendations, and regulations.

MERP provides a methodology to measure performance against benchmark standards of practice.

DECREASE COSTS & INEFFICIENCIES

Radiation oncology is an exceedingly complicated system where accidents happen. Any single error, combination, and propagation of errors in radiation oncology can negatively impact patient outcomes.  An error reduction program helps institutions minimize risk to patients and health care workers.

MERP is a medical error reduction software program specifically designed to help minimize errors, improve performance, reduce cost, lessen liability, decrease regulatory infractions, and positively contribute to patient outcomes in the radiation oncology treatment delivery process. 

TRANSFORM  YOUR PATIENT SAFETY 

Ineffective error management can lead to reduced quality, increased inefficiency, and increased legal and/or regulatory liabilities.

MERP is a powerful tool for implementing proactive risk reduction through error analysis and action plans. MERP facilitates a comprehensive approach to improving patient safety through the reduction of preventable systems-related errors.